Search Results 11-20 of 16454 for Emicizumab
Hematology — Learn about innovative diagnosis and treatment options for blood diseases, including cancers, at Mayo Clinic.
Duvelisib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as CC-486, cyclophosphamide, ...
This study will assess the ability of the Pathos platform to predict which patients will respond to certain colorectal cancer drug treatments. To demonstrate ...
Alemtuzumab injection is used to treat the relapsing forms of multiple sclerosis (MS), including relapsing-remitting disease and active secondary progressive ...
This randomized phase III trial studies cytarabine and daunorubicin hydrochloride or idarubicin and cytarabine with or without vorinostat to see how well they ...
Inotuzumab ozogamicin injection is used to treat acute lymphoblastic leukemia (ALL) that has come back or after other medicines did not work well. Leukemia is a ...
Emicizumab-kxwh (subcutaneous route). Hemofil-M. Also known as. Antihemophilic factor (intravenous route). Hemorrodil. Also known as. Zinc oxide (topical ...
The parent study consists of a screening period, a 24-week treatment period, which includes 4 weeks of pre-treatment with dupilumab or placebo followed by 12 ...
The purpose of this study is to compare IgG4-related disease remission and relapse rates between patients who had induction rituximab treatment with or without ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!